ALPORT SYNDROME
Clinical trials for ALPORT SYNDROME explained in plain language.
Never miss a new study
Get alerted when new ALPORT SYNDROME trials appear
Sign up with your email to follow new studies for ALPORT SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for kids with rare kidney diseases: sparsentan trial launches
Disease control Recruiting nowThis study tests an experimental drug called sparsentan in 67 children with certain kidney diseases that cause protein leakage in urine. The goal is to see if the drug safely reduces protein levels over 108 weeks. Participants take the drug once daily as a liquid or tablet, and r…
Matched conditions: ALPORT SYNDROME
Phase: PHASE2 • Sponsor: Travere Therapeutics, Inc. • Aim: Disease control
Last updated May 26, 2026 06:06 UTC
-
New hope for rare kidney disease: drug targets protein to slow damage
Disease control Recruiting nowThis study tests a new drug, BAY 3401016, in 60 adults aged 18 to 45 with Alport syndrome, a rare genetic condition that damages kidneys. The drug blocks a protein thought to cause kidney harm, aiming to slow the loss of kidney function. Participants receive either the drug or a …
Matched conditions: ALPORT SYNDROME
Phase: PHASE2 • Sponsor: Bayer • Aim: Disease control
Last updated May 26, 2026 06:03 UTC
-
Alport patients needed for landmark registry to speed up research
Knowledge-focused Recruiting nowThis study is a patient registry for people living with Alport syndrome in the US. Participants share their health history through a secure online portal to help researchers better understand the disease and support future clinical trials. The goal is to enroll 750 participants o…
Matched conditions: ALPORT SYNDROME
Sponsor: Alport Syndrome Foundation • Aim: Knowledge-focused
Last updated May 26, 2026 06:03 UTC
-
Personalized trial matching could revolutionize kidney care
Knowledge-focused Recruiting nowThis study helps people with nephrotic syndrome and related kidney diseases find clinical trials that may be a good fit for their specific condition. Researchers use detailed molecular information from each participant to recommend targeted therapies being tested in other studies…
Matched conditions: ALPORT SYNDROME
Phase: NA • Sponsor: University of Michigan • Aim: Knowledge-focused
Last updated May 26, 2026 06:03 UTC
-
Major study launches to map rare kidney Disease's natural course
Knowledge-focused Recruiting nowThis study follows 700 people with Alport syndrome, a rare inherited disease that can cause kidney failure, hearing loss, and eye problems. Researchers will collect health data over time to see how the disease progresses and to find early signs of kidney decline. The goal is to p…
Matched conditions: ALPORT SYNDROME
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated May 22, 2026 14:04 UTC